Pharmaceutical drugs supplied by: Par Pharmaceutical Inc.
✉ Email this page to a colleague
Par Pharmaceutical Inc.
Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.
| Applicant | Tradename | Generic Name | Dosage | NDA | NDA/ANDA | Supplier | Package Code | Package | Marketing Start |
|---|---|---|---|---|---|---|---|---|---|
| Abbvie | CARAFATE | sucralfate | SUSPENSION;ORAL | 019183 | NDA AUTHORIZED GENERIC | Par Pharmaceutical Inc. | 0254-1011-96 | 420 mL in 1 BOTTLE (0254-1011-96) | 2020-01-27 |
| Strides Pharma | OMEGA-3-ACID ETHYL ESTERS | omega-3-acid ethyl esters | CAPSULE;ORAL | 203893 | ANDA | Par Pharmaceutical Inc. | 0254-3010-08 | 120 CAPSULE in 1 BOTTLE (0254-3010-08) | 2017-09-19 |
| Fresenius Kabi Usa | LEVOTHYROXINE SODIUM | levothyroxine sodium | POWDER;INTRAVENOUS | 202231 | NDA | Par Pharmaceutical Inc. | 42023-201-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (42023-201-01) / 5 mL in 1 VIAL, SINGLE-DOSE | 2011-06-24 |
| Fresenius Kabi Usa | LEVOTHYROXINE SODIUM | levothyroxine sodium | POWDER;INTRAVENOUS | 202231 | NDA | Par Pharmaceutical Inc. | 42023-202-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (42023-202-01) / 5 mL in 1 VIAL, SINGLE-DOSE | 2011-06-24 |
| Fresenius Kabi Usa | LEVOTHYROXINE SODIUM | levothyroxine sodium | POWDER;INTRAVENOUS | 202231 | NDA | Par Pharmaceutical Inc. | 42023-203-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (42023-203-01) / 5 mL in 1 VIAL, SINGLE-DOSE | 2011-06-24 |
| Ani Pharms | ATACAND | candesartan cilexetil | TABLET;ORAL | 020838 | NDA AUTHORIZED GENERIC | Par Pharmaceutical Inc. | 49884-658-09 | 90 TABLET in 1 BOTTLE (49884-658-09) | 2013-05-21 |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >NDA/ANDA | >Supplier | >Package Code | >Package | >Marketing Start |
